Skip to main content

Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer

Medical Oncology volume 31, Article number: 22 (2014) Cite this article

Abstract

Previous studies have suggested an association between preoperative plasma fibrinogen and D-dimer levels and prognosis in patients with non-small cell lung cancer (NSCLC) who underwent surgery. In this study, we evaluate the value of pre- and post-operative plasma fibrinogen and D-dimer levels and changes in the levels of the two markers between before and after operation in predicting tumor recurrence and metastasis in NSCLC patients who undergoing radical surgery. One hundred and eighty-four patients with I–IIIA NSCLC were enrolled in this study, and plasma fibrinogen and D-dimer levels were measured in these patients before and after surgery, respectively. The results showed that pre- and post-operative plasma fibrinogen and D-dimer levels were significantly higher in NSCLC patients than in control group. Pre- and post-operative plasma fibrinogen and D-dimer positivities were significantly correlated with tumor recurrence (P = 0.020 and P = 0.001 for fibrinogen, and P = 0.027 and P = 0.001 for D-dimer). Moreover, there was a significant link between the decrease in fibrinogen and D-dimer levels after surgery and tumor recurrence (P = 0.014 and P = 0.018). Patients with pre- and post-operative fibrinogen and D-dimer positivities had a shorter disease-free survival (DFS) than those without (P = 0.002 and P < 0.001 for fibrinogen, and P = 0.003 and P = 0.001 for D-dimer). Multivariate Cox regression analyses revealed that pre- and post-operative fibrinogen and D-dimer positivities were independent predictors for unfavorable DFS. Our results indicate that pre- and post-operative plasma fibrinogen and D-dimer levels may be useful biomarkers in predicting tumor recurrence and metastasis for patients who undergo curative surgery.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Brundage MD, Dvies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer. Chest. 2002;122:1037–57.

    PubMed  Article  Google Scholar 

  2. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–43.

    CAS  PubMed  Article  Google Scholar 

  3. Asamura H, Goya T, Kashiishi Y, Sohara Y, Eguchi K, Mori M, Japanese Joint Committee of Lung Cancer Registry, et al. Japanes Lung Cancer Registry Study: prognosis of 13,010 resected lung cancer. J Thorac Oncol. 2008;3:46–52.

    PubMed  Article  Google Scholar 

  4. Pantel K, Alix-Panabieres C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol. 2009;6:339–51.

    CAS  PubMed  Article  Google Scholar 

  5. Rut W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost. 2006;32(Supp1 1):61–8.

    Google Scholar 

  6. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 2004;64:8613–9.

    CAS  PubMed  Article  Google Scholar 

  7. Palumbo JS, Degen JL. Fibrinogen and tumor cell metastasis. Haemostasis. 2001;31(suppl 1):11–5.

    CAS  PubMed  Google Scholar 

  8. Batschauer APB, Figueiredo CP, Bueno EC, Ribeiro MA, Dusse LMS, Fernandes AP, et al. D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Ann Oncol. 2010;21:1267–72.

    CAS  PubMed  Article  Google Scholar 

  9. Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389–95.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  10. Blackwell K, Hurwitz H, Lieberman G, Novotny W, Snyder S, Dewhirst M, et al. Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastasis colorectal carcinoma. Cancer. 2004;101:77–82.

    CAS  PubMed  Article  Google Scholar 

  11. Kwon H-C, Oh SY, Lee S, Kim S-H, Han JY, Koh RY, et al. Plasma levels of prothrombin fragment F1 + 2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol. 2008;38:2–7.

    PubMed  Article  Google Scholar 

  12. Khoury JD, Adcock DM, Chan F, Symanowski JT, Tiefenbacher S, Goodman O, et al. Increases in quantitative D-dimer levels correlated with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. Am J Clin Pathol. 2010;134:964–9.

    CAS  PubMed  Article  Google Scholar 

  13. Diao D, Zhu K, Wang Z, Cheng Y, Li K, Pei L, et al. Prognostic value of the D-dimer test in esophageal cancer during the perioperative period. J Surg Oncol. 2013;108:34–41.

    CAS  PubMed  Article  Google Scholar 

  14. Tsimafeyeu IV, Demidov LV, Madzhuga AV, Somonova O, Yelizarova AL. Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma. J Exp Clin Cancer Res. 2009;28:30.

    PubMed Central  PubMed  Article  Google Scholar 

  15. Yamashita H, Kitayama J, Nagawa H. Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol. 2005;35:595–600.

    PubMed  Article  Google Scholar 

  16. Antonion D, Pavlakou G, Stathopoulos GP, Karydis I, Chondrou E, Papageorgiouc C, et al. Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer. Lung Cancer. 2006;53:205–10.

    Article  Google Scholar 

  17. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, et al. High plasma D-dimer levels is associated with decreased survival in patients with lung cancer. Clin Oncol. 2007;19:494–8.

    CAS  Article  Google Scholar 

  18. Jones JM, McGonigle NC, McAnespie M, Cran GM, Graham AN. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer. 2006;53:97–101.

    PubMed  Article  Google Scholar 

  19. Sheng L, Luo M, Sun X, Lin N, Mao W, Su D. Serum fibrinogen is an independent prognostic factor in operable non-small cell lung cancer. Int J Cancer. 2013;133:2720–5.

    CAS  PubMed  Article  Google Scholar 

  20. Zhao J, Zhao M, Jin B, Yu P, Hu X, Teng Y, et al. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen. BMC Cancer. 2012;12:330.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  21. Zhang PP, Sun JW, Wang XY, Liu XM, Li K. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism. Eur J Surg Oncol. 2013;39:951–6.

    CAS  PubMed  Article  Google Scholar 

  22. Green FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

    Google Scholar 

  23. Wojtukiewicz MZ, Sierko E, Klemont P, Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia. 2001;3:371–84.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  24. Chiarug V, Ruggiero M, Magnelli L. Angiogenesis and the unique nature of tumor matrix. Mol Biothechnol. 2002;21:85–90.

    Article  Google Scholar 

  25. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumor that mediates lung metastasis. Cancer Cell. 2004;5:365–73.

    CAS  PubMed  Article  Google Scholar 

  26. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, Kowalska MA, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res. 2004;64:8613–9.

    CAS  PubMed  Article  Google Scholar 

  27. Palumbo JS, Talmage KE, Massari JV, Lajeunesse CM, Flick MJ, Kombrinck KW, et al. Platelets and fibrin (ogen) increase metastatic potential by impeding natured killer cell-mediated elimination of tumor cells. Blood. 2005;105:178–85.

    CAS  PubMed  Article  Google Scholar 

  28. Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JH, Degen JL, et al. Fibrinogen is an important determinant of the metastatic potential of circulation tumor cells. Blood. 2000;96:3302–9.

    CAS  PubMed  Google Scholar 

  29. Palumbo JS, Potter JM, Kaplan LS, Talmage K, Jackson DG, Degen JL. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminish in fibrinogen-deficient mice. Cancer Res. 2002;62:6966–72.

    CAS  PubMed  Google Scholar 

  30. Schneider J, Velcovsky HG, Morr H, Katz N, Neu K, Eigenbrodt E. Comparison of the tumor markers tumor Mz-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer. Anticancer Res. 2000;20:5053–8.

    CAS  PubMed  Google Scholar 

  31. Schneider J. Tumor markers in detection of lung cancer. Adv Clin Chem. 2006;42:1–41.

    CAS  PubMed  Article  Google Scholar 

  32. Kulpa J, Wojcik E, Reinfuss M, Kdodziejski L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. Clin Chem. 2002;48:1931–7.

    CAS  PubMed  Google Scholar 

  33. Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, et al. Decline serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced non small cell lung cancer. Cancer. 2006;107:2842–9.

    CAS  PubMed  Article  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Affiliations

  1. Department of Pulmonary Medicine, Affiliated Hospital of Jiangsu University, 438 North Jiefang Street, Zhenjiang, 212001, China

    He-Guo Jiang, Jian Li, Ping Chen, Li-Ping Ge & Xin-Ping Tang

  2. Department of Thoracic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China

    Shun-Bing Shi

  3. Center of Experimental Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China

    Qian Jiang

Authors
  1. He-Guo Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shun-Bing Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li-Ping Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qian Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xin-Ping Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Li.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jiang, HG., Li, J., Shi, SB. et al. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Med Oncol 31, 22 (2014). https://doi.org/10.1007/s12032-014-0022-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0022-8

Keywords

  • Non-small cell lung cancer
  • Fibrinogen
  • D-dimer
  • Surgery
  • Recurrence
  • Metastasis